Wonvas 20 Tablet contains Rosuvastatin 20 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing the clearance of LDL particles from the bloodstream. Wonvas 20 is used as an adjunct to diet and lifestyle modifications in patients at risk of cardiovascular disease, including those with familial hypercholesterolemia or established atherosclerotic cardiovascular disease. Clinical benefits include the reduction of the risk of myocardial infarction, stroke, and the need for coronary revascularization procedures. The tablet should be administered once daily, with or without food, preferably at the same time each day. Caution is advised in patients with hepatic or renal impairment, and periodic monitoring of liver function tests and creatine kinase levels is recommended to detect potential adverse effects such as hepatotoxicity or myopathy. Wonvas 20 should be used under medical supervision to ensure optimal safety and efficacy.